Heartfelt Advances: ACC 2024 Clinical Trials Spotlight-New Horizons in Heart Failure Management

The American College of Cardiology, 2024, (ACC.24) Annual Scientific Session offered a plethora of new clinical science within which were heart failure – centric data qualifying as transformative research and advances in clinical practice. Among the highlights were reaffirming trials, groundbreaking data, unanticipated results, and innovative therapeutic strategies with both null but informative data, and definitive outcomes. Regardless of the findings, all of these data will lead to future work, either validating positive findings or further exploring null results. Once again, the metric of successful investigation is the spur for more study. Herein, we briefly review those trials in heart failure (HF) with salient data igniting excitement among attendees, and ongoing deep conversations addressing relevance and new direction.